• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测胃癌根治性胃切除术后的腹膜复发:基于韩国数据库验证预测模型(PERI-Gastric 1 和 PERI-Gastric 2)。

Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.

机构信息

Università Cattolica del Sacro Cuore, Rome, Italy.

Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea; Gastric Cancer Center, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea.

出版信息

Eur J Surg Oncol. 2024 Jun;50(6):108359. doi: 10.1016/j.ejso.2024.108359. Epub 2024 Apr 19.

DOI:10.1016/j.ejso.2024.108359
PMID:38657377
Abstract

BACKGROUND

Peritoneal recurrence is a significant cause of treatment failure after radical gastrectomy for gastric cancer. The prediction of metachronous peritoneal recurrence would have a significantly impact risk stratification and tailored treatment planning. This study aimed to externally validate the previously established PERI-Gastric 1 and 2 models to assess their generalizability in an independent population.

METHODS

Retrospective external validation was conducted on a cohort of 8564 patients who underwent elective gastrectomy for stage Ib-IIIc gastric cancer between 1998 and 2018 at the Yonsei Cancer Center. Discrimination was tested using the area under the receiver operating characteristic curves (AUROC). Accuracy was tested by plotting observations against the predicted risk of peritoneal recurrence and analyzing the resulting calibration plots. Clinical usefulness was tested with a decision curve analysis.

RESULTS

In the validation cohort, PERI-Gastric 1 and PERI-Gastric 2 exhibited an AUROC of 0.766 (95 % C.I. 0.752-0.778) and 0.767 (95 % C.I. 0.755-0.780), a calibration-in-the-large of 0.935 and 0.700, a calibration belt with a 95 % C.I. over the bisector in the risk range of 24%-33 % and 35%-47 %. The decision curve analysis revealed a positive net benefit in the risk range of 10%-42 % and 15%-45 %, respectively.

CONCLUSIONS

This study presents the external validation of the PERI-Gastric 1 and 2 scores in an Eastern population. The models demonstrated fair discrimination and satisfactory calibration for predicting the risk of peritoneal recurrence after radical gastrectomy, even in Eastern patients. PERI-Gastric 1 and 2 scores could also be applied to predict the risk of metachronous peritoneal recurrence in Eastern populations.

摘要

背景

腹膜复发是胃癌根治性胃切除术后治疗失败的一个重要原因。对异时性腹膜复发的预测将对风险分层和针对性治疗计划产生重大影响。本研究旨在对先前建立的 PERI-Gastric 1 和 2 模型进行外部验证,以评估其在独立人群中的通用性。

方法

对 1998 年至 2018 年在延世癌症中心接受择期胃癌根治术的 8564 例 Ib-IIIc 期胃癌患者的队列进行回顾性外部验证。使用接收者操作特征曲线下面积(AUROC)来测试区分度。通过绘制观测值与腹膜复发预测风险的关系图,并分析由此产生的校准图来测试准确性。通过决策曲线分析来测试临床实用性。

结果

在验证队列中,PERI-Gastric 1 和 PERI-Gastric 2 的 AUROC 分别为 0.766(95%CI 0.752-0.778)和 0.767(95%CI 0.755-0.780),大校准率为 0.935 和 0.700,校准带在 24%-33%和 35%-47%的风险范围内,95%CI 在二分线以上。决策曲线分析显示,在 10%-42%和 15%-45%的风险范围内,分别存在正净获益。

结论

本研究在东亚人群中进行了 PERI-Gastric 1 和 2 评分的外部验证。这些模型在预测根治性胃切除术后腹膜复发风险方面表现出良好的区分度和令人满意的校准度,即使在东亚患者中也是如此。PERI-Gastric 1 和 2 评分也可应用于预测东亚人群的异时性腹膜复发风险。

相似文献

1
Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.预测胃癌根治性胃切除术后的腹膜复发:基于韩国数据库验证预测模型(PERI-Gastric 1 和 PERI-Gastric 2)。
Eur J Surg Oncol. 2024 Jun;50(6):108359. doi: 10.1016/j.ejso.2024.108359. Epub 2024 Apr 19.
2
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer.胃周(腹膜复发指数)和胃周-gram(腹膜复发指数诺莫格拉姆)的制定,用于预测胃癌根治性胃切除术后发生异时性腹膜癌病的风险。
Gastric Cancer. 2022 May;25(3):629-639. doi: 10.1007/s10120-021-01268-4. Epub 2021 Nov 22.
3
Novel nomogram and risk stratification for peritoneal recurrence after curative resection in gastric cancer.胃癌根治术后腹膜复发的新型列线图和风险分层。
Sci Rep. 2024 Aug 17;14(1):19103. doi: 10.1038/s41598-024-70349-y.
4
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.验证两种用于预测胃癌根治术后复发和生存的预后模型。
Br J Surg. 2017 Aug;104(9):1235-1243. doi: 10.1002/bjs.10551. Epub 2017 May 10.
5
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer: a methodology issue.用于预测胃癌根治性胃切除术后异时性腹膜癌转移风险的胃周(腹膜复发指数)和胃周图(腹膜复发指数诺模图)的开发:一个方法学问题。
Gastric Cancer. 2022 Nov;25(6):1129-1130. doi: 10.1007/s10120-022-01337-2. Epub 2022 Sep 3.
6
Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.竞争风险列线图预测胃癌患者 D2 胃切除术后初始局部区域复发。
Radiat Oncol. 2019 Jul 17;14(1):128. doi: 10.1186/s13014-019-1332-y.
7
Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.列线图预测接受根治性胃切除术和不完全围手术期辅助化疗的 II/III 期胃癌患者的总生存期:一项回顾性双中心队列研究。
BMC Cancer. 2024 Mar 18;24(1):344. doi: 10.1186/s12885-024-12103-1.
8
Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.根治性切除的进展期胃癌患者术中评估的宏观浆膜变化:对预后和腹膜复发的临床意义
Ann Surg Oncol. 2015 Sep;22(9):2940-7. doi: 10.1245/s10434-014-4352-8. Epub 2015 Jan 21.
9
Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.胃癌肿瘤微环境免疫全景分析鉴定出与腹膜复发相关的免疫特征。
Front Immunol. 2021 May 13;12:651033. doi: 10.3389/fimmu.2021.651033. eCollection 2021.
10
Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer.转录组谱分析鉴定出用于预测胃癌腹膜复发和微转移的风险分层特征。
Clin Cancer Res. 2021 Apr 15;27(8):2292-2300. doi: 10.1158/1078-0432.CCR-20-3835. Epub 2021 Feb 8.